Chapter 2 Summary and Highlights
- Market Outlook
- Market Insights
Chapter 3 Market Overview
- Introduction
- Future Perspectives
Chapter 4 Market Dynamics
- Market Drivers
- Rising Prevalence of Chronic and Infectious Diseases Globally
- Increasing Adoption of Ai in Pharmaceutical Sector
- Potential of Ai in Pharma Sector
- Market Restraints
- Challenges With Ai in Drug Discovery
- Market Opportunities
- Partnerships and Mergers Between Sectors
Chapter 5 Regulatory Landscape and Reimbursement Scenario
- Regulatory Landscape
- North America
- Europe
- Asia-Pacific
Chapter 6 Impact of Covid-19 on Market
- Overview
- Covid-19 Crisis
- Covid-19 Drug Discovery and Vaccine Development Using Ai
- Impact of Covid-19 on Ai in Drug Discovery
- Covid-19 Measures
Chapter 7 Market Breakdown by Application
- Applications of Ai in Drug Discovery
- Preclinical Testing
- Target Identification
- Candidate Screening and Lead Optimization
- Drug Repurposing
- De Novo Drug Design
- Other Applications
Chapter 8 Market Breakdown by Therapeutic Area
- Ai in Drug Discovery by Therapeutic Area
- Oncology
- Infectious Diseases
- Neurodegenerative Diseases
- Cardiovascular Diseases
- Metabolic Diseases
- Other Diseases
Chapter 9 Market Breakdown by Region
- Overview
- North America
- U.S. Market Size and Forecast
- Canadian Market Size and Forecast
- Europe
- German Market Size and Forecast
- U.K. Market Size and Forecast
- French Market Size and Forecast
- Italian Market Size and Forecast
- Spanish Market Size and Forecast
- Rest of European Market Size and Forecast
- Asia-Pacific
- Chinese Market Size and Forecast
- Japanese Market Size and Forecast
- Indian Market Size and Forecast
- South Korean Market Size and Forecast
- Rest of Asia-Pacific Market Size and Forecast
- Rest of the World
- South American Market Size and Forecast
- Middle East and African Market Size and Forecast
Chapter 10 Esg Development
- Introduction to Esg
- Environmental
- Social
- Government
- The Sustainability of Ai Suppliers in Drug Discovery Industry
- Pharma End-user Sustainability in the Ai Industry
- Case Study
- Concluding Remarks
Chapter 11 Emerging Technologies and Developments
- Overview
- Current Market Trends
- Emerging Technologies
- Cell Painting
- Quantum Computing
- Metabolomics
Chapter 12 M&A and Funding Outlook
- M&A Analysis
- Major Strategic Alliances
Chapter 13 Competitive Landscape
- Competitive Analysis
- Vision and Strategy for Ai
- Technology and Data
- External Ai Collaborations
- Managing Internal Talent
- Culture and Methods of Work
- Company Share Analysis
Chapter 14 Company Profiles
- Aria Pharmaceuticals Inc.
- Atomwise Inc.
- Benevolentai
- Exscientia plc
- Insilico Medicine
- Recursion Pharmaceuticals Inc.
- Relay Therapeutics Inc.
- Schrodinger Inc.
- Xtalpi Inc.
List of Tables
Summary Table: Global Market for AI in Drug Discovery, by Application, Through 2028
Table 1: Global Totals of Angina Pectoris and Stroke Survivors, Through 2030
Table 2: Global Incidence and Prevalence of All Stroke Types, 2019
Table 3: Global Prevalence of Congestive Heart Failure and Stroke, Through 2030
Table 4: Global Diabetes Prevalence, Estimates and Projections, 2019-2045
Table 5: Cases of Diabetes Worldwide, by Type, 2019
Table 6: Global Prevalence of Diabetes, by Type, Through 2040
Table 7: Global Prevalence of Breast Cancer Cases, by Country/Region, Through 2025
Table 8: Global Epidemiology of Colorectal Cancer, by Region, Through 2030
Table 9: Global Occurrences of Deaths, by Various Cancer Types, Through 2030
Table 10: Breakdown of Global Deaths Due to Cancer, by Various Cancer Types, 2021
Table 11: Prevalence of Multiple Sclerosis, by Region, 2013 and 2020
Table 12: Global Prevalence of Symptomatic Key Musculoskeletal Disorders, Through 2025
Table 13: Global Occurrences of Deaths, by Various Musculoskeletal Disorders, Through 2030
Table 14: Global Occurrences of Deaths from Digestive Diseases, by Region, Through 2025
Table 15: Global HIV Epidemic, by Age Group, 2020
Table 16: Global Market for AI in Drug Discovery, by Application, Through 2028
Table 17: Global Market for AI in Preclinical Testing Application, by Region, Through 2028
Table 18: Global Market for AI in Target Identification Application, by Region, Through 2028
Table 19: Global Market for AI in Candidate Screening and Lead Optimization Application, by Region, Through 2028
Table 20: Global Market for AI in Drug Repurposing Application, by Region, Through 2028
Table 21: Global Market for AI in De Novo Drug Design Application, by Region, Through 2028
Table 22: Global Market for AI in Other Drug Discovery Applications, by Region, Through 2028
Table 23: Global Market for AI in Drug Discovery, by Therapeutic Area, Through 2028
Table 24: Global Market for AI in Drug Discovery for Oncology, by Region, Through 2028
Table 25: Global Market for AI in Drug Discovery in Infectious Diseases, by Region, Through 2028
Table 26: Global Market for AI in Drug Discovery in Neurodegenerative Diseases, by Region, Through 2028
Table 27: Global Market AI in Drug Discovery in Cardiovascular Diseases, by Region, Through 2028
Table 28: Share of Global Diabetes Cases, by Type
Table 29: Global Market for AI in Drug Discovery in Metabolic Diseases, by Region, Through 2028
Table 30: Global Market for AI in Drug Discovery in Other Diseases, by Region, Through 2028
Table 31: Global Market for AI in Drug Discovery, by Region, Through 2028
Table 32: Diabetes Estimates in North America, by Country, 2000-2045
Table 33: Influenza Disease Burden in the U.S., by Age Group, 2019-2020 Influenza Season
Table 34: North American Market for AI in Drug Discovery, by Country, Through 2028
Table 35: Diabetes Estimates in Europe, by Country, 2000-2045
Table 36: European Market for AI in Drug Discovery, by Country, Through 2028
Table 37: Tuberculosis Burden of Asian Countries, by Country, 2019
Table 38: Diabetes Estimates for the Asia-Pacific Region, by Country, 2000-2045
Table 39: Asia-Pacific Market for AI in Drug Discovery, by Country, Through 2028
Table 40: Diabetes Estimates in the RoW, by Country, 2000-2045
Table 41: Estimation of New Cancer Cases in Africa, by Cancer Type, 2020 and 2024
Table 42: Rest of the World Market for AI in Drug Discovery, by Sub-region, Through 2028
Table 43: Key Focus Areas in ESG Metrics
Table 44: ESG Rankings for Few AI Companies for Drug Discovery, 2023
Table 45: ESG Rankings for Major Pharma Companies Utilizing AI for Drug Discovery, 2023
Table 46: Major Strategic Alliances, AI in Drug Discovery Market, 2018-2023
Table 47: Aria Pharmaceuticals: Pipeline Products
Table 48: Aria Pharmaceuticals: AI Offerings
Table 49: Atomwise: Pipeline Products
Table 50: Atomwise: AI Offerings
Table 51: Atomwise: News/Developments, 2019-2022
Table 52: BenevolentAI: Pipeline Products
Table 53: BenevolentAI: AI Offerings
Table 54: BenevolentAI: Annual Revenue, 2022
Table 55: Benevolent AI: News/Developments, 2019-2023
Table 56: Exscientia Plc: Pipeline Products
Table 57: Exscientia Plc: AI Offerings
Table 58: Exscientia Plc: Annual Revenue, 2022
Table 59: Exscientia Plc: News/Developments, 2021-2022
Table 60: Insilico Medicine: Pipeline Products
Table 61: Insilico Medicine: AI Offerings
Table 62: Insilico Medicine: News/Developments, 2021-2023
Table 63: Recursion: Pipeline Products
Table 64: Recursion: AI Offerings
Table 65: Recursion: Annual Revenue, 2022
Table 66: Recursion: News/Developments, 2021-2023
Table 67: Relay Therapeutics: Pipeline Products
Table 68: Relay Therapeutics: AI Offerings
Table 69: Relay Therapeutics: Annual Revenue, 2022
Table 70: Relay Therapeutics: News/Developments, 2019-2022
Table 71: Schrödinger: Pipeline Products
Table 72: Schrödinger: Pipeline Products - II Collaborative Programs
Table 73: Schrödinger: AI Offerings
Table 74: Schrödinger: Annual Revenue, 2022
Table 75: Schrödinger: News/Developments, 2020-2022
Table 76: XtalPi: AI Offerings
Table 77: XtalPi: News/Developments, 2021-2023
Table 78: Acronyms Used in This Report
List of Figures
Summary Figure: Global Market Shares of AI in Drug Discovery, by Application, 2022
Figure 1: Traditional vs. AI-Based Drug Delivery Techniques
Figure 2: Timeline of AI in Drug Discovery Industry
Figure 3: Growth of AI in Drug Discovery in Initial Phases, 2013-2021
Figure 4: Breakdown of Worldwide Diabetes Cases, by Type, 2019
Figure 5: Global Prevalence of Diabetes, by Type, 2018 and 2040
Figure 6: Breakdown of New Cancer Cases in Women, by Cancer Type, 2020
Figure 7: Breakdown of New Cancer Cases in Men, by Cancer Type, 2020
Figure 8: Global Prevalence of Breast Cancer Cases, by Country/Region, 2015-2025
Figure 9: Global Epidemiology of Colorectal Cancer, by Region, 2000-2030
Figure 10: Global Occurrences of Deaths, by Various Cancer Types, 2000-2030
Figure 11: Breakdown of Global Deaths Due to Cancer, by Various Cancer Types, 2021
Figure 12: Global Prevalence of Symptomatic Key Musculoskeletal Disorders, by Region, 2018
Figure 13: Breakdown of Global Occurrences of Deaths, by Various Musculoskeletal Disorders, 2015
Figure 14: Global Occurrences of Deaths from Digestive Diseases, by Region, 2015-2025
Figure 15: Top Pharma Companies AI Deals, by Company, 2020
Figure 16: Top AI and Tech Partners and Pharma Deals, by Company, 2020
Figure 17: Applications of AI in Drug Discovery
Figure 18: Global Market for AI in Preclinical Testing Application, 2020-2028
Figure 19: Global Market for AI in Target Identification Application, 2020-2028
Figure 20: Global Market for AI in Candidate Screening and Lead Optimization Application, 2020-2028
Figure 21: Drug Repurposing Approaches
Figure 22: Global Market for AI in Drug Repurposing Application, 2020-2028
Figure 23: Global Market for AI in De Novo Drug Design Application, 2020-2028
Figure 24: Global Market for AI in Other Drug Discovery Applications, 2020-2028
Figure 25: Global Market for AI in Drug Discovery for Oncology, 2020-2028
Figure 26: Global Market for AI in Drug Discovery in Infectious Diseases, 2020-2028
Figure 27: Global Market for AI in Drug Discovery in Neurodegenerative Diseases, 2020-2028
Figure 28: Global Market for AI in Drug Discovery in Cardiovascular Diseases, 2020-2028
Figure 29: Share of Global Diabetes Cases, by Type
Figure 30: Global Market for AI in Drug Discovery in Metabolic Diseases, 2020-2028
Figure 31: Global Market for AI in Drug Discovery in Other Diseases, 2020-2028
Figure 32: Global Market Shares of AI in Drug Discovery, by Region, 2022
Figure 33: North American Market for AI in Drug Discovery, by Country, 2020-2028
Figure 34: Share of Cancer Diagnosis in Europe, by Gender, 2020
Figure 35: European Market for AI in Drug Discovery, by Country, 2020-2028
Figure 36: Asia-Pacific Market for AI in Drug Discovery, by Country, 2020-2028
Figure 37: Rest of the World Market for AI in Drug Discovery, by Sub-region, 2020-2028
Figure 38: How a Strong ESG Proposition Benefits Businesses
Figure 39: ESG-Adoption Level Across All the Industries, Global, 2021 and 2022
Figure 40: The Ten Business Sustainability Trends Identified for 2022
Figure 41: Key Sustainable Practices Being Implemented in Research Laboratories
Figure 42: ESG Commitments of Recursion
Figure 43: Emerging Technologies in the AI in Drug Discovery Market
Figure 44: Venture Capital Deals Including Corporate Pharma and Biotech Investors, by Year, 2013-2022
Figure 45: Investments in the AI in Drug Discovery Industry, by Year, 2014-2020
Figure 46: Shares of Global Market for AI in Drug Discovery, by Company, 2022
Figure 47: BenevolentAI: Annual Revenue, 2021 and 2022
Figure 48: Exscientia Plc: Annual Revenue, 2021 and 2022
Figure 49: Exscientia Plc: Revenue Share, by Country/Region, 2022
Figure 50: Recursion: Annual Revenue, 2021 and 2022
Figure 51: Relay Therapeutics: Annual Revenue, 2021 and 2022
Figure 52: Schrödinger: Annual Revenue, 2021 and 2022
Figure 53: Schrödinger: Revenue Share, by Segment, 2022
Figure 54: Schrödinger: Revenue Share, by Region/Country, 2022
